Andrzej K. Bednarek was not included as an author in the published article. The corrected Author Contributions Statement appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
DK and AKB conceptualized the article. DK, ŻK, AKB, and EP established methodology. DK and ŻK were responsible for software. AKB and EP supervised the article. DK and ŻK visualized the results. DK wrote the original draft. DK, ŻK, and EP reviewed and edited the article.
Summary
Keywords
bladder cancer, WWOX, TFAP2A, TFAP2C, AP-2alpha, AP-2gamma
Citation
Kołat D, Kałuzińska Ż, Bednarek AK and Płuciennik E (2021) Corrigendum: Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer. Front. Oncol. 11:735435. doi: 10.3389/fonc.2021.735435
Received
02 July 2021
Accepted
05 July 2021
Published
26 August 2021
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2021
Updates
Copyright
© 2021 Kołat, Kałuzińska, Bednarek and Płuciennik.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Damian Kołat, damian.kolat@stud.umed.lodz.pl
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.